339 related articles for article (PubMed ID: 31781725)
1. Is Polypharmacy Associated with Cognitive Frailty in the Elderly? Results from the Korean Frailty and Aging Cohort Study.
Moon JH; Huh JS; Won CW; Kim HJ
J Nutr Health Aging; 2019; 23(10):958-965. PubMed ID: 31781725
[TBL] [Abstract][Full Text] [Related]
2. How do potentially inappropriate medications and polypharmacy affect mortality in frail and non-frail cognitively impaired older adults? A cohort study.
Porter B; Arthur A; Savva GM
BMJ Open; 2019 May; 9(5):e026171. PubMed ID: 31092652
[TBL] [Abstract][Full Text] [Related]
3. Is Polypharmacy Associated with Frailty in Older People? Results From the ESTHER Cohort Study.
Saum KU; Schöttker B; Meid AD; Holleczek B; Haefeli WE; Hauer K; Brenner H
J Am Geriatr Soc; 2017 Feb; 65(2):e27-e32. PubMed ID: 28024089
[TBL] [Abstract][Full Text] [Related]
4. Medication exposure and frailty in older community-dwelling patients: a cross-sectional study.
Reallon E; Chavent B; Gervais F; Dauphinot V; Vernaudon J; Krolak-Salmon P; Mouchoux C; Novais T
Int J Clin Pharm; 2020 Apr; 42(2):508-514. PubMed ID: 32140916
[TBL] [Abstract][Full Text] [Related]
5. The Korean version of the FRAIL scale: clinical feasibility and validity of assessing the frailty status of Korean elderly.
Jung HW; Yoo HJ; Park SY; Kim SW; Choi JY; Yoon SJ; Kim CH; Kim KI
Korean J Intern Med; 2016 May; 31(3):594-600. PubMed ID: 26701231
[TBL] [Abstract][Full Text] [Related]
6. Impact of Cognitive Frailty on Daily Activities in Older Persons.
Shimada H; Makizako H; Lee S; Doi T; Lee S; Tsutsumimoto K; Harada K; Hotta R; Bae S; Nakakubo S; Harada K; Suzuki T
J Nutr Health Aging; 2016; 20(7):729-35. PubMed ID: 27499306
[TBL] [Abstract][Full Text] [Related]
7. Relationship between frailty and drug use among nursing homes residents: results from the SHELTER study.
Villani ER; Vetrano DL; Liperoti R; Palmer K; Denkinger M; van der Roest HG; Bernabei R; Onder G
Aging Clin Exp Res; 2021 Oct; 33(10):2839-2847. PubMed ID: 33590468
[TBL] [Abstract][Full Text] [Related]
8. Impaired mobility, depressed mood, cognitive impairment and polypharmacy are independently associated with disability in older cancer outpatients: The prospective Physical Frailty in Elderly Cancer patients (PF-EC) cohort study.
Pamoukdjian F; Aparicio T; Zelek L; Boubaya M; Caillet P; François V; de Decker L; Lévy V; Sebbane G; Paillaud E
J Geriatr Oncol; 2017 May; 8(3):190-195. PubMed ID: 28236586
[TBL] [Abstract][Full Text] [Related]
9. Polypharmacy and Lack of Joy Are Related to Physical Frailty among Northern Japanese Community-Dwellers from the ORANGE Cohort Study.
Kume Y; Takahashi T; Itakura Y; Lee S; Makizako H; Ono T; Shimada H; Ota H
Gerontology; 2021; 67(2):184-193. PubMed ID: 33503617
[TBL] [Abstract][Full Text] [Related]
10. Physical Frailty Is Associated with Longitudinal Decline in Global Cognitive Function in Non-Demented Older Adults: A Prospective Study.
Chen S; Honda T; Narazaki K; Chen T; Kishimoto H; Haeuchi Y; Kumagai S
J Nutr Health Aging; 2018; 22(1):82-88. PubMed ID: 29300426
[TBL] [Abstract][Full Text] [Related]
11. Polypharmacy at discharge in older hospitalised patients in Vietnam and its association with frailty.
Nguyen TX; Nguyen TN; Nguyen AT; Nguyen HTT; Nguyen TTH; Nguyen TN; Pham T; Vu HTT
Australas J Ageing; 2020 Sep; 39(3):230-236. PubMed ID: 31677221
[TBL] [Abstract][Full Text] [Related]
12. Validation of the Korean Version of the SARC-F Questionnaire to Assess Sarcopenia: Korean Frailty and Aging Cohort Study.
Kim S; Kim M; Won CW
J Am Med Dir Assoc; 2018 Jan; 19(1):40-45.e1. PubMed ID: 28843526
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and associated factors of cognitive frailty in community-dwelling older adults: Results from the Korean longitudinal study of aging.
Lee T; Chung J; Song K; Ji Y
Int J Older People Nurs; 2023 Nov; 18(6):e12576. PubMed ID: 37776018
[TBL] [Abstract][Full Text] [Related]
14. Differential association of frailty with cognitive decline and sarcopenia in community-dwelling older adults.
Nishiguchi S; Yamada M; Fukutani N; Adachi D; Tashiro Y; Hotta T; Morino S; Shirooka H; Nozaki Y; Hirata H; Yamaguchi M; Arai H; Tsuboyama T; Aoyama T
J Am Med Dir Assoc; 2015 Feb; 16(2):120-4. PubMed ID: 25244957
[TBL] [Abstract][Full Text] [Related]
15. Cognitive Performance across 3 Frailty Phenotypes: Toledo Study for Healthy Aging.
Rosado-Artalejo C; Carnicero JA; Losa-Reyna J; Guadalupe-Grau A; Castillo-Gallego C; Gutierrez-Avila G; Alfaro-Acha A; Rodríguez-Artalejo F; Rodríguez-Mañas L; García-García FJ
J Am Med Dir Assoc; 2017 Sep; 18(9):785-790. PubMed ID: 28623151
[TBL] [Abstract][Full Text] [Related]
16. Polypharmacy is associated with frailty in Japanese community-dwelling older adults.
Yuki A; Otsuka R; Tange C; Nishita Y; Tomida M; Ando F; Shimokata H
Geriatr Gerontol Int; 2018 Oct; 18(10):1497-1500. PubMed ID: 30168240
[TBL] [Abstract][Full Text] [Related]
17. Prescribing in the oldest old inpatients: a retrospective analysis of patients referred for specialist geriatric consultation.
Ilango S; Pillans P; Peel NM; Scott I; Gray LC; Hubbard RE
Intern Med J; 2017 Sep; 47(9):1019-1025. PubMed ID: 28632340
[TBL] [Abstract][Full Text] [Related]
18. Nutritional Status and Frailty in Community-Dwelling Older Korean Adults: The Korean Frailty and Aging Cohort Study.
Kim J; Lee Y; Won CW; Lee KE; Chon D
J Nutr Health Aging; 2018; 22(7):774-778. PubMed ID: 30080218
[TBL] [Abstract][Full Text] [Related]
19. Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes.
Gnjidic D; Hilmer SN; Blyth FM; Naganathan V; Waite L; Seibel MJ; McLachlan AJ; Cumming RG; Handelsman DJ; Le Couteur DG
J Clin Epidemiol; 2012 Sep; 65(9):989-95. PubMed ID: 22742913
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
